These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16801165)

  • 21. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
    Zeng P; Li F; Zeng H
    Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
    Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
    Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does red-man reaction stimulate macrophage activation syndrome in children with systemic juvenile idiopathic arthritis?
    Olgar S; Ertugrul T; Devecioglu O; Nisli K; Omeroglu RE
    J Rheumatol; 2007 Dec; 34(12):2491-4. PubMed ID: 18061966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept in the treatment of macrophage activation syndrome.
    Prahalad S; Bove KE; Dickens D; Lovell DJ; Grom AA
    J Rheumatol; 2001 Sep; 28(9):2120-4. PubMed ID: 11550985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis.
    Ramanan AV; Rosenblum ND; Feldman BM; Laxer RM; Schneider R
    J Rheumatol; 2004 Oct; 31(10):2068-70. PubMed ID: 15468377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan.
    Chen HH; Kuo HC; Wang L; Yu HR; Shen JM; Kwang KP; Yang KD
    J Microbiol Immunol Infect; 2007 Jun; 40(3):265-71. PubMed ID: 17639169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis.
    Kounami S; Yoshiyama M; Nakayama K; Okuda M; Okuda S; Aoyagi N; Yoshikawa N
    Acta Haematol; 2005; 113(2):124-9. PubMed ID: 15802891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage activation syndrome and other systemic inflammatory conditions after BMT.
    Sreedharan A; Bowyer S; Wallace CA; Robertson MJ; Schmidt K; Woolfrey AE; Nelson RP
    Bone Marrow Transplant; 2006 Apr; 37(7):629-34. PubMed ID: 16501594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.
    Fall N; Barnes M; Thornton S; Luyrink L; Olson J; Ilowite NT; Gottlieb BS; Griffin T; Sherry DD; Thompson S; Glass DN; Colbert RA; Grom AA
    Arthritis Rheum; 2007 Nov; 56(11):3793-804. PubMed ID: 17968951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Macrophage activation syndrome secondary to Still disease].
    Tapia Ceballos L; Picazo Angelin B; Romero Sánchez J; Díaz Cabrera R; Romero Narbona F; Romero González J
    An Esp Pediatr; 1999 Aug; 51(2):194-6. PubMed ID: 10495510
    [No Abstract]   [Full Text] [Related]  

  • 32. [Haemophagocytic syndrome: A common pathogenic mechanism of various aetiologies].
    Dapena Díaz JL; Díaz de Heredia Rubio C; Bastida Vila P; Llort Sales A; Elorza Alvarez I; Olivé Oliveras T; Sánchez de Toledo Codina J
    An Pediatr (Barc); 2009 Aug; 71(2):110-6. PubMed ID: 19481995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients.
    Stéphan JL; Koné-Paut I; Galambrun C; Mouy R; Bader-Meunier B; Prieur AM
    Rheumatology (Oxford); 2001 Nov; 40(11):1285-92. PubMed ID: 11709613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage activation syndrome.
    Ravelli A
    Curr Opin Rheumatol; 2002 Sep; 14(5):548-52. PubMed ID: 12192253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Ravelli A; Magni-Manzoni S; Pistorio A; Besana C; Foti T; Ruperto N; Viola S; Martini A
    J Pediatr; 2005 May; 146(5):598-604. PubMed ID: 15870661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemophagocytic syndrome: diagnostic problems].
    Czogała M; Czogała W; Balwierz W
    Przegl Lek; 2006; 63(1):47-52. PubMed ID: 16892901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome.
    Shimizu M; Yokoyama T; Tokuhisa Y; Ishikawa S; Sakakibara Y; Ueno K; Yachie A
    Clin Immunol; 2013 Feb; 146(2):73-6. PubMed ID: 23291246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.